Celyad Oncology: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

About this update from Celyad Oncology Sa

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/14da37cb6f945eb4d14ed35a473cde16"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gR9pZjVyz9v6bV.VSiSY9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/14da37cb6f945eb4d14ed35a473cde16","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/zp2ciMoam5F1_oR8O49SAQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/14da37cb6f945eb4d14ed35a473cde16","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MONT-SAINT-GUIBERT, Belgium, November 25, 2025--(BUSINESS WIRE)--Regulatory News:","length":81,"tagName":"p"},{"type":"text","content":"Celyad Oncology SA (Euronext: CYAD) ("Celyad Oncology" or the "Company") today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the "Transparency Law"), that it received a notification of transparency dated November 20, 2025, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has passively crossed above the 65% threshold, holding 49,050,641 voting rights, i.e. 67.77% of Celyad Oncology’s voting rights.","length":620,"tagName":"p"},{"type":"text","content":"Content of the Notification:","length":28,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Reason of the Notification:Passive crossing of a threshold","length":59,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":59,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Notification by:A parent undertaking or a controlling person","length":61,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":61,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Persons subject to the notification requirement:Fortress Investment Group LLC - 1345 Avenue of the Americas, New York, NY 10105 United StatesCFIP CLYD (UK) Limited - 7 Clarges Street, 4th Floor, London W1J 8AE, United Kingdom","length":227,"tagName"...

More updates from Celyad Oncology Sa